Skip to main content
Top
Published in: Orphanet Journal of Rare Diseases 1/2018

Open Access 01-12-2018 | Research

X-linked Alport syndrome: pathogenic variant features and further auditory genotype-phenotype correlations in males

Authors: Xiao Zhang, Yanqin Zhang, Yanmei Zhang, Hongbo Gu, Zhe Chen, Lei Ren, Xingxing Lu, Li Chen, Fang Wang, Yuhe Liu, Jie Ding

Published in: Orphanet Journal of Rare Diseases | Issue 1/2018

Login to get access

Abstract

Objective

To analyze the clinical audiological characteristics of X-Linked Alport syndrome (XLAS) in males and their relationships with genotypes.

Methods

The clinical data of 87 male patients with AS were reviewed. Hearing levels were evaluated using pure tone audiometry (PTA) testing, acoustic immittance, and otoacoustic emissions (OAE) testing. The genotypes of COL4A5 and the pathogenic variants were analyzed. The relationships between auditory phenotypes and genotypes were analyzed.

Results

Among the 87 patients, the number of patients with normal hearing and hearing loss were 32 and 55, respectively. In all cases, the hearing loss was characterized as bilateral symmetrical sensorineural deafness. Majority of the patients had mild-to-moderate hearing loss. Hearing loss usually started in the middle frequency range and gradually affected high frequencies, at school age and gradually increased with increasing age. However, it maintained a relatively steady level of 50–60 dB HL during the teenage years. The audiometric curves included groove-type in 51 cases (92.73%). Patients were identified to have 60 different COL4A5 pathogenic variants. Of the 49 patients who were followed-up for more than 2 years, 28 cases presented a decreasing trend in the hearing level of about 5 dB per year. The degree of hearing loss was positively correlated with gene mutation type and renal function.

Conclusions

Hearing loss in males with XLAS is symmetrical sensorineural, and progressive with increasing age. There is a significant correlation between the degree of hearing loss and genotype, renal function, and age.
Literature
1.
go back to reference Kashtan CE. Alport syndrome and thin glomerular basement membrane disease. J Am Soc Nephrol. 1998;9(9):1736.PubMed Kashtan CE. Alport syndrome and thin glomerular basement membrane disease. J Am Soc Nephrol. 1998;9(9):1736.PubMed
2.
go back to reference Savige J, Gregory M, Gross O, et al. Expert guidelines for the management of alport syndrome and thin basement membrane nephropathy. J Am Soc Nephrol. 2013;24(3):364–75.CrossRef Savige J, Gregory M, Gross O, et al. Expert guidelines for the management of alport syndrome and thin basement membrane nephropathy. J Am Soc Nephrol. 2013;24(3):364–75.CrossRef
3.
go back to reference Barker DF, Hostikka SL, Zhou J, et al. Identification of mutations in the COL4A5 collagen gene in Alport syndrome. Science. 1990;248(4960):1224–7.CrossRef Barker DF, Hostikka SL, Zhou J, et al. Identification of mutations in the COL4A5 collagen gene in Alport syndrome. Science. 1990;248(4960):1224–7.CrossRef
4.
go back to reference Mochizuki T, Lemmink HH, Mariyama M, et al. Identification of mutations in the alpha 3(IV) and alpha 4(IV) collagen genes in autosomal recessive Alport syndrome. Nat Genet. 1994;8(1):77–81.CrossRef Mochizuki T, Lemmink HH, Mariyama M, et al. Identification of mutations in the alpha 3(IV) and alpha 4(IV) collagen genes in autosomal recessive Alport syndrome. Nat Genet. 1994;8(1):77–81.CrossRef
5.
go back to reference Hudson BG, Tryggvason K, Sundaramoorthy M. Alport’s syndrome, Goodpasture's syndrome, and type IV collagen. N Engl J Med. 2009;348(25):2543–56.CrossRef Hudson BG, Tryggvason K, Sundaramoorthy M. Alport’s syndrome, Goodpasture's syndrome, and type IV collagen. N Engl J Med. 2009;348(25):2543–56.CrossRef
6.
go back to reference Kalluri R. Basement membranes: structure, assembly and role in tumour angiogenesis. Nat Rev Cancer. 2003;3(6):422–33.CrossRef Kalluri R. Basement membranes: structure, assembly and role in tumour angiogenesis. Nat Rev Cancer. 2003;3(6):422–33.CrossRef
7.
go back to reference Zehnder AF, Adams JC, Santi PA, et al. Distribution of type IV collagen in the cochlea in Alport syndrome. Arch Otolaryngol Head Neck Surg. 2005;131(11):1007–13.CrossRef Zehnder AF, Adams JC, Santi PA, et al. Distribution of type IV collagen in the cochlea in Alport syndrome. Arch Otolaryngol Head Neck Surg. 2005;131(11):1007–13.CrossRef
8.
go back to reference Brazel D, Oberbäumer I, Dieringer H, et al. Completion of the amino acid sequence of the alpha 1 chain of human basement membrane collagen (type IV) reveals 21 non-triplet interruptions located within the collagenous domain. FEBS J. 1987;168(3):529–36. Brazel D, Oberbäumer I, Dieringer H, et al. Completion of the amino acid sequence of the alpha 1 chain of human basement membrane collagen (type IV) reveals 21 non-triplet interruptions located within the collagenous domain. FEBS J. 1987;168(3):529–36.
9.
go back to reference Merchant SN, Burgess BJ, Adams JC, et al. Temporal bone histopathology in alport syndrome. Laryngoscope. 2004;114(9):1609–18.CrossRef Merchant SN, Burgess BJ, Adams JC, et al. Temporal bone histopathology in alport syndrome. Laryngoscope. 2004;114(9):1609–18.CrossRef
10.
go back to reference Cosgrove D, Samuelson G, Meehan DT, et al. Ultrastructural, physiological, and molecular defects in the inner ear of a gene-knockout mouse model for autosomal Alport syndrome. Hear Res. 1998;121(1–2):84–98.CrossRef Cosgrove D, Samuelson G, Meehan DT, et al. Ultrastructural, physiological, and molecular defects in the inner ear of a gene-knockout mouse model for autosomal Alport syndrome. Hear Res. 1998;121(1–2):84–98.CrossRef
11.
go back to reference Kleppel MM, Santi PA, Cameron JD, et al. Human tissue distribution of novel basement membrane collagen. Am J Pathol. 1989;134(4):813.PubMedPubMedCentral Kleppel MM, Santi PA, Cameron JD, et al. Human tissue distribution of novel basement membrane collagen. Am J Pathol. 1989;134(4):813.PubMedPubMedCentral
12.
go back to reference Perkoff GT, Stephens FE, Dolowitz DA, et al. A clinical study of hereditary interstitial pyelonephritis. Arch Intern Med. 1951;88(2):191–200.CrossRef Perkoff GT, Stephens FE, Dolowitz DA, et al. A clinical study of hereditary interstitial pyelonephritis. Arch Intern Med. 1951;88(2):191–200.CrossRef
13.
go back to reference Cassady G, Brown K, Cohen M, DeMaria W. Hereditary renal dysfunction and deafness. Pediatrics. 1965;35:967–79.PubMed Cassady G, Brown K, Cohen M, DeMaria W. Hereditary renal dysfunction and deafness. Pediatrics. 1965;35:967–79.PubMed
14.
go back to reference Gubler M, Levy M, Broyer M, et al. Alport’s syndrome. A report of 58 cases and a review of the literature. Am J Med. 1981;70(3):493–505.CrossRef Gubler M, Levy M, Broyer M, et al. Alport’s syndrome. A report of 58 cases and a review of the literature. Am J Med. 1981;70(3):493–505.CrossRef
15.
go back to reference Gross O, Netzer K, Lambrecht R, et al. Meta-analysis of genotype-phenotype correlation in X-linked Alport syndrome: impact on clinical counselling. Nephrol Dial Transplant. 2002;17(7):1218–27.CrossRef Gross O, Netzer K, Lambrecht R, et al. Meta-analysis of genotype-phenotype correlation in X-linked Alport syndrome: impact on clinical counselling. Nephrol Dial Transplant. 2002;17(7):1218–27.CrossRef
16.
go back to reference Jais JP, Knebelmann B, Giatras I, et al. X-linked Alport syndrome natural history in 195 families and genotype- phenotype correlations in males. J Am Soc Nephrol. 2000;11(4):649–57.PubMed Jais JP, Knebelmann B, Giatras I, et al. X-linked Alport syndrome natural history in 195 families and genotype- phenotype correlations in males. J Am Soc Nephrol. 2000;11(4):649–57.PubMed
17.
go back to reference Flinter FA, Cameron JS, Chantler C, et al. Genetics of classic Alport's syndrome. Lancet. 1988;2(8618):1005–7.CrossRef Flinter FA, Cameron JS, Chantler C, et al. Genetics of classic Alport's syndrome. Lancet. 1988;2(8618):1005–7.CrossRef
18.
go back to reference Gleeson MJ. Alport’s syndrome: audiological manifestations and implications. J Laryngol Otol. 1984;98(5):449–65.CrossRef Gleeson MJ. Alport’s syndrome: audiological manifestations and implications. J Laryngol Otol. 1984;98(5):449–65.CrossRef
19.
go back to reference Wester DC, Atkin CL, Gregory MC. Alport syndrome: clinical update. J Am Acad Audiol. 1995;6(1):73–9.PubMed Wester DC, Atkin CL, Gregory MC. Alport syndrome: clinical update. J Am Acad Audiol. 1995;6(1):73–9.PubMed
20.
go back to reference Alves FR, de A Guintanilha Ribeiro F. Revision about hearing loss in the Alport’s syndrome, analyzing the clinical, genetic and bio-molecular aspects. Braz J Otorhinolaryngol. 2005;71(6):813–9.CrossRef Alves FR, de A Guintanilha Ribeiro F. Revision about hearing loss in the Alport’s syndrome, analyzing the clinical, genetic and bio-molecular aspects. Braz J Otorhinolaryngol. 2005;71(6):813–9.CrossRef
21.
go back to reference Chen L, Xue J, Zhang Y, et al. Chin J Otorhinolaryngol Head Neck Surg. 2014;49(11):902–7. Chen L, Xue J, Zhang Y, et al. Chin J Otorhinolaryngol Head Neck Surg. 2014;49(11):902–7.
22.
go back to reference Zhang Y, Ding J. Renal, auricular, and ocular outcomes of Alport syndrome and their current management. Pediatr Nephrol. 2018;33:1309–16.CrossRef Zhang Y, Ding J. Renal, auricular, and ocular outcomes of Alport syndrome and their current management. Pediatr Nephrol. 2018;33:1309–16.CrossRef
23.
go back to reference Richards S, Aziz N, Bale S, et al. ACMG laboratory quality assurance committee. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17(5):405–24.CrossRef Richards S, Aziz N, Bale S, et al. ACMG laboratory quality assurance committee. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17(5):405–24.CrossRef
24.
go back to reference Wang F, Wang Y, Ding J, et al. Detection of mutations in the COL4A5 gene by analyzing cDNA of skin fibroblasts. Kidney Int. 2005;67:1268–74.CrossRef Wang F, Wang Y, Ding J, et al. Detection of mutations in the COL4A5 gene by analyzing cDNA of skin fibroblasts. Kidney Int. 2005;67:1268–74.CrossRef
25.
go back to reference Wang F, Zhang Y, Mao J, et al. Spectrum of mutations in Chinese children with steroid-resistant nephrotic syndrome. Pediatr Nephrol. 2017;32(7):1181–92.CrossRef Wang F, Zhang Y, Mao J, et al. Spectrum of mutations in Chinese children with steroid-resistant nephrotic syndrome. Pediatr Nephrol. 2017;32(7):1181–92.CrossRef
26.
go back to reference Alves FRA. Clinical data and hearing of individuals with Alport syndrome. Braz J Otorhinolaryngol. 2008;74(6):807–14.CrossRef Alves FRA. Clinical data and hearing of individuals with Alport syndrome. Braz J Otorhinolaryngol. 2008;74(6):807–14.CrossRef
27.
go back to reference Miner JH, Baigent C, Flinter F, et al. The 2014 international workshop on Alport syndrome. Kidney Int. 2014;86(4):679–84.CrossRef Miner JH, Baigent C, Flinter F, et al. The 2014 international workshop on Alport syndrome. Kidney Int. 2014;86(4):679–84.CrossRef
28.
go back to reference Wang F, Zhao D, Ding J, et al. Skin biopsy is a practical approach for the clinical diagnosis and molecular genetic analysis of X-linked Alport’s syndrome. J Mol Diagn. 2012;14(6):586–93.CrossRef Wang F, Zhao D, Ding J, et al. Skin biopsy is a practical approach for the clinical diagnosis and molecular genetic analysis of X-linked Alport’s syndrome. J Mol Diagn. 2012;14(6):586–93.CrossRef
29.
go back to reference Kruegel J, Rubel D, Gross O. Alport syndrome--insights from basic and clinical research. Nat Rev Nephrol. 2013;9(3):170–8.CrossRef Kruegel J, Rubel D, Gross O. Alport syndrome--insights from basic and clinical research. Nat Rev Nephrol. 2013;9(3):170–8.CrossRef
30.
go back to reference Bekheirnia MR, Reed B, Gregory MC, et al. Genotype-phenotype correlation in X-linked Alport syndrome. J Am Soc Nephrol. 2010;21(5):876–83.CrossRef Bekheirnia MR, Reed B, Gregory MC, et al. Genotype-phenotype correlation in X-linked Alport syndrome. J Am Soc Nephrol. 2010;21(5):876–83.CrossRef
31.
go back to reference Barker DF, Pruchno CJ, Jiang X, et al. A mutation causing Alport syndrome with tardive hearing loss is common in the western United States. Am J Hum Genet. 1996;58(6):1157.PubMedPubMedCentral Barker DF, Pruchno CJ, Jiang X, et al. A mutation causing Alport syndrome with tardive hearing loss is common in the western United States. Am J Hum Genet. 1996;58(6):1157.PubMedPubMedCentral
32.
go back to reference Lemmink HH, Kluijtmans LA, Brunner HG, et al. Aberrant splicing of the COL4A5 gene in patients with Alport syndrome. Hum Mol Gen. 1994;3(2):317.CrossRef Lemmink HH, Kluijtmans LA, Brunner HG, et al. Aberrant splicing of the COL4A5 gene in patients with Alport syndrome. Hum Mol Gen. 1994;3(2):317.CrossRef
33.
go back to reference Renieri A, Meroni M, Sessa A, et al. Variability of clinical phenotype in a large Alport family with Gly 1143 Ser change of collagen alpha 5(IV)-chain. Nephron. 1994;67(4):444–9.CrossRef Renieri A, Meroni M, Sessa A, et al. Variability of clinical phenotype in a large Alport family with Gly 1143 Ser change of collagen alpha 5(IV)-chain. Nephron. 1994;67(4):444–9.CrossRef
34.
go back to reference Xue JF, Nozu K, Eguchi A, et al. X-linked Alport syndrome associated with a synonymous p.Gly292Gly mutation alters the splicing donor site of the type IV collagen alpha chain 5 gene. Clin Exp Nephrol. 2015;20(5):1–4. Xue JF, Nozu K, Eguchi A, et al. X-linked Alport syndrome associated with a synonymous p.Gly292Gly mutation alters the splicing donor site of the type IV collagen alpha chain 5 gene. Clin Exp Nephrol. 2015;20(5):1–4.
Metadata
Title
X-linked Alport syndrome: pathogenic variant features and further auditory genotype-phenotype correlations in males
Authors
Xiao Zhang
Yanqin Zhang
Yanmei Zhang
Hongbo Gu
Zhe Chen
Lei Ren
Xingxing Lu
Li Chen
Fang Wang
Yuhe Liu
Jie Ding
Publication date
01-12-2018
Publisher
BioMed Central
Published in
Orphanet Journal of Rare Diseases / Issue 1/2018
Electronic ISSN: 1750-1172
DOI
https://doi.org/10.1186/s13023-018-0974-4

Other articles of this Issue 1/2018

Orphanet Journal of Rare Diseases 1/2018 Go to the issue